Outcomes related to delayed initiation of anti-HER 2 therapy in pregnant HER2 positive breast cancer patients.

Oke, O; Warneke, CL; Gregor, MCM; Milbourne, A; Litton, JK

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):